A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study

1. Elbehairy, AF, Ciavaglia, CE, Webb, KA, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med 2015; 191: 1384–1394.
Google Scholar | Crossref | Medline2. Maltais, F, Decramer, M, Casaburi, R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189: e15–e62.
Google Scholar | Crossref | Medline3. Da Silva, GP, Morano, MT, Cavalcante, AG, et al. Exercise capacity impairment in COPD patients with comorbidities. Rev Port Pneumol (2006) 2015; 21: 233–238.
Google Scholar | Medline4. Global initiative for chronic obstructive lung disease . Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. 2020 ed., www.goldcopd.org (2020, 8 July 2020).
Google Scholar5. Magnussen, H, Paggiaro, P, Schmidt, H, et al. Effect of combination treatment on lung volumes and exercise endurance time in COPD. Respir Med 2012; 106: 1413–1420.
Google Scholar | Crossref | Medline | ISI6. Maltais, F, Hamilton, A, Marciniuk, D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128: 1168–1178.
Google Scholar | Crossref | Medline | ISI7. Vivodtzev, I, Gagnon, P, Pepin, V, et al. Physiological correlates of endurance time variability during constant-workrate cycling exercise in patients with COPD. PLoS ONE 2011; 6: e17007.
Google Scholar | Crossref | Medline8. Worth, H, Forster, K, Eriksson, G, et al. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respir Med 2010; 104: 1450–1459.
Google Scholar | Crossref | Medline9. American Thoracic Society and American College of Chest Physicians . ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211–277.
Google Scholar | Crossref | Medline | ISI10. Palange, P, Ward, SA, Carlsen, KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185–209.
Google Scholar | Crossref | Medline | ISI11. O’Donnell, DE, Elbehairy, AF, Berton, DC, et al. Exercise testing in the evaluation of pharmacotherapy in COPD. In: Palange, P, Laveneziana, P, Neder, JA (eds) Clinical exercise testing (ERS monograph). Sheffield: European Respiratory Society, 2018, pp. 235–250.
Google Scholar | Crossref12. Andrianopoulos, V, Wagers, SS, Groenen, MT, et al. Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD. BMC Pulm Med 2014; 14: 97.
Google Scholar | Crossref | Medline13. Degani-Costa, LH, O’Donnell, DE, Webb, K, et al. A simplified approach to select exercise endurance intensity for interventional studies in COPD. COPD 2018; 15: 139–147.
Google Scholar | Crossref | Medline14. Puente-Maestu, L, Palange, P, Casaburi, R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J 2016; 47: 429–460.
Google Scholar | Crossref | Medline | ISI15. Cazzola, M, MacNee, W, Martinez, FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416–469.
Google Scholar | Crossref | Medline | ISI16. Radtke, T, Crook, S, Kaltsakas, G, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev 2019; 28: 180101.
Google Scholar | Crossref | Medline17. Eriksson, G, Radner, F, Peterson, S, et al. A new maximal bicycle test using a prediction algorithm developed from four large COPD studies. Eur Clin Respir J 2020; 7: 1692645.
Google Scholar | Crossref | Medline18. Tufvesson, E, Radner, F, Papapostolou, G, et al. Reduced variability of endurance time in new protocols for exercise tests in COPD. Int J Chron Obstruct Pulmon Dis 2020; 15: 3003–3012.
Google Scholar | Crossref | Medline19. van der Molen, T, Willemse, BW, Schokker, S, et al. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes 2003; 1: 13.
Google Scholar | Crossref | Medline20. Borg, GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377–381.
Google Scholar | Crossref | Medline | ISI21. Crapo, RO, Morris, AH, Gardner, RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659–664.
Google Scholar | Medline | ISI22. van der Ploeg, T, Austin, PC, Steyerberg, EW. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med Res Methodol 2014; 14: 137.
Google Scholar | Crossref | Medline23. Steele, AJ, Denaxas, SC, Shah, AD, et al. Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PLoS ONE 2018; 13: e0202344.
Google Scholar | Crossref24. Debigare, R, Maltais, F, Mallet, M, et al. Influence of work rate incremental rate on the exercise responses in patients with COPD. Med Sci Sports Exerc 2000; 32: 1365–1368.
Google Scholar | Crossref | Medline25. Puente-Maestu, L, Villar, F, de Miguel, J, et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J 2009; 34: 340–345.
Google Scholar | Crossref | Medline26. Berton, DC, Marques, RD, Palmer, B, et al. Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD. Respir Med 2019; 157: 59–68.
Google Scholar | Crossref | Medline27. Beeh, KM, Korn, S, Beier, J, et al. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study. Respir Med 2014; 108: 584–592.
Google Scholar | Crossref | Medline | ISI28. Maltais, F, Singh, S, Donald, AC, et al. Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials. Ther Adv Respir Dis 2014; 8: 169–181.
Google Scholar | SAGE Journals | ISI29. Maltais, F, O’Donnell, D, Galdiz Iturri, JB, et al. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease. Ther Adv Respir Dis 2018; 12: 1753465818755091.
Google Scholar | SAGE Journals | ISI30. O’Donnell, DE, Casaburi, R, Frith, P, et al. Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD. Eur Respir J 2017; 49: 1601348.
Google Scholar | Crossref | Medline31. Watz, H, Troosters, T, Beeh, KM, et al. ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 2545–2558.
Google Scholar | Crossref | Medline32. Calzetta, L, Rogliani, P, Ora, J, et al. LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. Eur Respir Rev 2017; 26: 160043.
Google Scholar | Crossref | Medline33. Rossi, A, Aisanov, Z, Avdeev, S, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 2015; 109: 785–802.
Google Scholar | Crossref | Medline34. Di Marco, F, Sotgiu, G, Santus, P, et al. Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis. Respir Res 2018; 19: 18.
Google Scholar | Crossref | Medline35. O’Donnell, DE, Casaburi, R, Vincken, W, et al. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med 2011; 105: 1030–1036.
Google Scholar | Crossref | Medline | ISI36. Eriksson, G, Jarenback, L, Peterson, S, et al. A new approach to assess COPD by identifying lung function break-points. Int J Chron Obstruct Pulmon Dis 2015; 10: 2193–2202.
Google Scholar | Crossref | Medline37. Jarenback, L, Eriksson, G, Peterson, S, et al. Bronchodilator response of advanced lung function parameters depending on COPD severity. Int J Chron Obstruct Pulmon Dis 2016; 11: 2939–2950.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif